Metastatic Large Cell Neuroendocrine Carcinoma Combined with Gastric Adenocarcinoma |
Cho, Kun-Hyung
(Department of Internal Medicine, College of Medicine, Kyung Hee University)
Chang, Young-Woon (Department of Internal Medicine, College of Medicine, Kyung Hee University) Sohn, Seong-Dong (Department of Internal Medicine, College of Medicine, Kyung Hee University) HwangBo, Young (Department of Internal Medicine, College of Medicine, Kyung Hee University) Shim, Jae-Jun (Department of Internal Medicine, College of Medicine, Kyung Hee University) Jang, Jae-Young (Department of Internal Medicine, College of Medicine, Kyung Hee University) Kim, Hyo-Jong (Department of Internal Medicine, College of Medicine, Kyung Hee University) Kim, Byung-Ho (Department of Internal Medicine, College of Medicine, Kyung Hee University) |
1 | Moertel CG, Kvols LK, O'Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasm. Cancer 1991;68:227-232. DOI ScienceOn |
2 | Pidoto RR, Piquard A, Fama F, Saint Marc O. Lymph node metastasis from gastric carcinoid tumors occurring concomitantly with gastric adenocarcinomas and atrophic gastritis. J Gastrointest Surg 2006;10:402-406. DOI ScienceOn |
3 | Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063-3072. DOI ScienceOn |
4 | Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 1995;425:547-560. |
5 | Ronellenfitsch U, Strobel P, Schwarzbach MH, Staiger WI, Gragert D, Kahler G. A composite adenoendocrine carcinoma of the stomach arising from a neuroendocrine tumor. J Gastrointest Surg 2007;11:1573-1575. DOI ScienceOn |
6 | Jung JH, Kim YC, Kim JH, et al. A case of a gastric composite tumor with an adenocarcinoma and a large cell neuroendocrine carcinoma. Korean J Gastrointest Endosc 2009;39:93-96. |
7 | Kloppel G. Tumour biology and histopathology of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 2007;21:15-31. DOI ScienceOn |
8 | Hainsworth JD, Spigel DR, Litchy S, Greco FA. Phase II trial of paciltaxel, carboplatin and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a minnie pearl cancer research network study. J Clin Oncol 2006;24:3548-3554. DOI ScienceOn |
9 | Oien KA. Pathologic evaluation of unknown primary cancer. Semin Oncol 2009;36:8-37. DOI ScienceOn |
10 | Hainsworth JD, Johnson DH, Greco FA. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med 1988; 109:364-371. DOI ScienceOn |